Waldenström's macroglobulinemia/lymphoplasmacytic lymphoma, version 2.2013: Featured updates to the NCCN guidelines Review uri icon

Overview

MeSH Major

  • Medical Oncology
  • Waldenstrom Macroglobulinemia

abstract

  • These NCCN Guidelines Insights highlight the important updates/changes specific to the management of Waldenström's Macroglobulinemia/Lymphoplasmacytic Lymphoma. These include the addition of regimens containing novel agents as primary and salvage therapy options, inclusion of the updated summary of response categories and criteria from the sixth international workshop on Waldenström's Macroglobulinemia, and a section on management of peripheral neuropathy in the accompanying discussion.

publication date

  • October 2012

Research

keywords

  • Review

Identity

Language

  • eng

PubMed ID

  • 23054875

Additional Document Info

start page

  • 1211

end page

  • 9

volume

  • 10

number

  • 10